Functional Cure for Hepatitis B Virus: Challenges and Achievements
International Journal of Molecular Sciences · 11.04.2025 · 26 (8) · 3633
DOI: 10.3390/ijms26083633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.04.2025. Verfasst von Oren Shechter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eastern Virginia Medical School, Norfolk, VA 23501, USA. Hauptthemen laut MEDLINE: Hepatitis B virus, Antiviral Agents, Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health grants, National Institutes of Health.
Abstract (Originalsprache)
The Hepatitis B Virus (HBV) presents a formidable global health challenge, impacting hundreds of millions worldwide and imposing a considerable burden on healthcare systems. The elusive nature of the virus, with its ability to establish chronic infection and evade immune detection, and the absence of curative agents have prompted efforts to develop novel therapeutic approaches beyond current antiviral treatments. This review addresses the challenging concept of a functional cure for HBV, a state characterized by the suppression of HBV and HBsAg, mitigating disease progression and transmission without a complete cure. We provide an overview of HBV epidemiology and its clinical impact, followed by an exploration of the current treatment landscape and its limitations. The immunological basis of a functional cure is then discussed, exploring the intricate interplay between the virus and the host immune response. Emerging therapeutic approaches, such as RNA interference-based interventions, entry inhibitors, nucleic acid polymers, and therapeutic vaccines, are discussed with regard to their success in achieving a functional cure. Lastly, the review underscores the urgent need for innovative strategies to achieve a functional cure for HBV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eastern Virginia Medical School, Norfolk, VA 23501, USA.
- Naval Medical Center Portsmouth, Portsmouth, VA 23708, USA.
- The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
- Replicor Inc., 6100 Royalmount Ave., Montreal, QC H4P 2R2, Canada.
ORCID-Profile: Harel Dahari, Andrew Vaillant, Ronen Borenstein
Förderung
- NIAID NIH HHS
- National Institutes of Health grants
- National Institutes of Health
Zitieren
APA
Shechter, O., Sausen, D. G., Dahari, H., Vaillant, A., Cotler, S. J., & Borenstein, R. (2025). Functional Cure for Hepatitis B Virus: Challenges and Achievements. International Journal of Molecular Sciences, 26(8), 3633. https://doi.org/10.3390/ijms26083633
Vancouver
Shechter O, Sausen DG, Dahari H, Vaillant A, Cotler SJ, Borenstein R. Functional Cure for Hepatitis B Virus: Challenges and Achievements. International Journal of Molecular Sciences. 2025;26(8):3633. doi:10.3390/ijms26083633
BibTeX
@article{Shechter2025,
author = {Shechter, Oren and Sausen, Daniel G and Dahari, Harel and Vaillant, Andrew and Cotler, Scott J and Borenstein, Ronen},
title = {Functional Cure for Hepatitis B Virus: Challenges and Achievements},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3633},
doi = {10.3390/ijms26083633}
}
EUVIMED